Análisis retrospectivo de pacientes que tomaban IECA/ARAII (publicado en Circulation). Se asoció con < mortalidad. Los resultados parecen robustos con n= 188vs940. Se mantiene < mortalidad en análisis ajustado y en el propensity score. https://t.
Interesting data and adjusted analyses for once suggesting chronic use of ACEI /ARB may be associated with lower mortality in #COVID19. But relatively low use in hypertension, different comorbidities and genetics vs. UK population. https://t.co/wto9BmM
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @NightShiftMD: It might just block the pathway through which #COVID19 penetrates the lungs.
Trish Greenhalgh is an international treasure with her consistent rigorous attention to evidence and her accessible methods of knowledge translation
RT @Rocioluarca: Para liarla más.... https://t.co/jWfer2nvuY
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
Important Trisha, I wonder how many people have stopped them
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @paomorejon: Quedaría mejor si le cambiamos un poco❓❤️ “Al menos daño no hacen” Difícil llegar a esa conclusión al ser retrospectivo ob…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 patients with hypertension, and may even be protective. Early days bc retrospective study, confounders, in-hospital etc. MT @kamleshkhunti
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @SantasEnrique: Datos que de nuevo refuerzan NO suspender IECA/ARA-2 en pacientes con HTA 🏥 por #COVID19. Menor riesgo de mortalidad e…
RT @DrRajivsankar: https://t.co/1GPwvDeGdD Retrospective data with associated limitations but lower mortality in hospitalised COVID patient…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circulation Research https://t.co/Z54mYcvsrk
RT @ABsteward: Surprising! @CircRes @CircAHA Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associat…
Još jedna retrospektivna studija, ovog puta sa recenzijom, u uglednom časopisu, pokazala je da su hipertenzivni (HT) #COVID19 bolesnici koji su HT lečili ACEi/ARB lekovima (njih 198), imali statistički značajno manju smrtnost od/sa COVID, u odnosu na ostal
RT @rincondesisifo: (Circulation) Uso de IECA y ARA2 en pac con HTA y #COVID19 hospitalizados y riesgo de mortalidad https://t.co/iRkVpyypE…
Para liarla más....
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @Derek_Leong_RPh: Retrospective study in Pts. with HTN hospitalized with #COVID19 showing in-hospital use of ACEi/ARB was associated wit…
IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitalized with #COVID19 in 9 Hospitals in China. Circ Res 2020. PMID: 32302265 Article: https://t.co/mpvHrCWpXA REBEL EM: https://t.co
Study shows that treatment with ACEi/ARB was associated with lower mortality in covid19. Retrospective design but so far the best data we have! https://t.co/eC1m1Bbr4z
RT @statsepi: Be mindful of potential collider bias here. It's not just patients with COVID-19 - it's patients with that *and* hypertension.
RT @DrRoderickTung: Nice illustration of how initial speculation based on isolated physiological upregulation of ACE2 may actually be the…
Thank God!
RT @Derek_Leong_RPh: Retrospective study in Pts. with HTN hospitalized with #COVID19 showing in-hospital use of ACEi/ARB was associated wit…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @SantasEnrique: Datos que de nuevo refuerzan NO suspender IECA/ARA-2 en pacientes con HTA 🏥 por #COVID19. Menor riesgo de mortalidad e…
RT @DrRoderickTung: Nice illustration of how initial speculation based on isolated physiological upregulation of ACE2 may actually be the…
RT @venkmurthy: I coauthored editorial on the paper w/ @RaviShah_MD Paper isn't perfect. *Lots* of limitations. Many of which are pointed…
Retrospective study in Pts. with HTN hospitalized with #COVID19 showing in-hospital use of ACEi/ARB was associated with ⬇️ 28d all-cause mortality & septic shock vs. no ACEi/ARB use (including use of other classes of BP meds). Let's see what RCTs show
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | https://t.co/bJpiK7nnjl| Glad to see this safety signal| @MPAlexander
RT @venkmurthy: I coauthored editorial on the paper w/ @RaviShah_MD Paper isn't perfect. *Lots* of limitations. Many of which are pointed…
RT @statsepi: Be mindful of potential collider bias here. It's not just patients with COVID-19 - it's patients with that *and* hypertension.
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
To ACEI/ARB or not to ACEI/ARB in COVID-19 dilemma. This is what Cohort Chinese Study says. #CirculationResearch https://t.co/UOqufCA6rt https://t.co/VstHicuPOR
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @ASPphysician: This paper is getting lots of attention: Assoc of Inpt use of ACEi/ARBs w/ Mortality Among Pts w/HT in Hospitalized COVID…
RT @NightShiftMD: It might just block the pathway through which #COVID19 penetrates the lungs. https://t.co/ZrXF5nHyRl
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @statsepi: Be mindful of potential collider bias here. It's not just patients with COVID-19 - it's patients with that *and* hypertension.
RT @statsepi: Be mindful of potential collider bias here. It's not just patients with COVID-19 - it's patients with that *and* hypertension.
RT @statsepi: Be mindful of potential collider bias here. It's not just patients with COVID-19 - it's patients with that *and* hypertension.
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 https://t.co/rij4QZTMJF
Quedaría mejor si le cambiamos un poco❓❤️ “Al menos daño no hacen” Difícil llegar a esa conclusión al ser retrospectivo observacional, análisis por propensión que no consideró otras variables q podrían tener un rol en la expresión de la ACE2 #COVIDー19 h
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @sciencecohen: This new study concludes: "...associated with lower risk of all-cause mortality compared with ACEI/ARB non-users... unl…
This is an important finding and is corroborated by the fact that SARS-COVID virus uses ACE receptor for infecting the cell.
RT @NightShiftMD: It might just block the pathway through which #COVID19 penetrates the lungs. https://t.co/ZrXF5nHyRl
It might just block the pathway through which #COVID19 penetrates the lungs.
RT @RogueRad: ACEI/ARB is associated with lower mortality in COVID. Does this study sufficiently debunk the opposite? https://t.co/UINi6JEG…
RT @venkmurthy: I coauthored editorial on the paper w/ @RaviShah_MD Paper isn't perfect. *Lots* of limitations. Many of which are pointed…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @KaminskiMed: Convincing? Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers…
Yet another beautiful hypothesis (possibly) ruined by an ugly clinical observation. Looking forward to the RCT ..... https://t.co/MrA04xM4u8
RT @RogueRad: ACEI/ARB is associated with lower mortality in COVID. Does this study sufficiently debunk the opposite? https://t.co/UINi6JEG…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @venkmurthy: I coauthored editorial on the paper w/ @RaviShah_MD Paper isn't perfect. *Lots* of limitations. Many of which are pointed…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
@DrEricDing @chrismartenson have you seen this?
RT @RogueRad: ACEI/ARB is associated with lower mortality in COVID. Does this study sufficiently debunk the opposite? https://t.co/UINi6JEG…
Interesting
RT @venkmurthy: I coauthored editorial on the paper w/ @RaviShah_MD Paper isn't perfect. *Lots* of limitations. Many of which are pointed…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @RogueRad: ACEI/ARB is associated with lower mortality in COVID. Does this study sufficiently debunk the opposite? https://t.co/UINi6JEG…
Fascinated by the ⬇️ risk of all- cause mortality in hospitalized #COVIDー19 patients on ACEi/ARB for hypertension. https://t.co/z9YqMaSiHE
RT @DavidBrenesMD: Myth partially #busted: Among hospitalized #COVID19 patients with #hypertension. Inpatient use of #ACEi/ARB was associat…